References
- Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and opioid-involved overdose deaths — United States, 2017–2018. MMWR Morb Mortal Wkly Rep. 2020 Mar;69:290–97. doi:https://doi.org/10.15585/mmwr.mm6911a4.
- Lambdin BH, Davis CS, Wheeler E, Tueller S, Kral AH. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States. Drug Alcohol Depend. 2018 Jul;188:370–76. doi:https://doi.org/10.1016/j.drugalcdep.2018.04.004.
- McClellan C, Lambdin BH, Ali MM, Mutter R, Davis CS, Wheeler E, Pemberton M, Kral AH. Opioid-overdose laws association with opioid use and overdose mortality. Addict Behav. 2018 Nov;86:90–95. doi:https://doi.org/10.1016/j.addbeh.2018.03.014.
- Hogan L, Rutherford B, Mitchell V. Statewide Naloxone Standing Order 2015. 2015. Available at:https://health.maryland.gov/pharmacy/docs/LegsRegs/Statewide-Naloxone-Standing-Order-combined.pdf [last accessed 1 Mar 2021].
- Guadamuz JS, Alexander GC, Chaudhri T, Trotzky-Sirr R, Qato DM. Availability and cost of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 2017. JAMA Network Open. 2019 Jun 5;2:e195388. doi:https://doi.org/10.1001/jamanetworkopen.2019.5388.
- Centers for Disease Control and Prevention. 2016-2017 drug overdose death rate increases [ Internet]. 2018 [accessed 2021 Mar 8]. https://www.cdc.gov/drugoverdose/data/statedeaths/drug-overdose-death-rate-increase-2016-2017.html .
- Abouk R, Pacula RL, Powell D. Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose. JAMA Intern Med. 2019 Jun;179:805–11. doi:https://doi.org/10.1001/jamainternmed.2019.0272.
- Maryland Department of Health and Mental Hygiene. Maryland Overdose Response program statewide naloxone standing order guidance for pharmacy dispensing [ Internet]. 2017 [accessed 2021 Mar 8]. https://bha.health.maryland.gov/NALOXONE/Documents/StatewideNaloxoneStandingOrderPharmacyGuidance5.31.17.pdf .
- Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174–f174.
- Office of Women’s Health. White paper: opioid use, misuse, and overdose in women [ Internet]. U.S. Department of Health and Human Services. 2016 [accessed 2021 Mar 8]. https://www.womenshealth.gov/files/documents/white-paper-opioid-508.pdf .
- The National Institute for Occupational Safety and Health. Opioids in the workplace [ Internet]. 2019 [accessed 2021 Mar 8]. https://www.cdc.gov/niosh/topics/opioids/data.html .
- Lippold KM, Jones CM, Olsen EOM, Giroir BP. Racial/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged ≥18 years in metropolitan areas - United States, 2015–2017. MMWR Morb Mortal Wkly Rep. 2019 Nov;68:967–73. doi:https://doi.org/10.15585/mmwr.mm6843a3.
- Substance Abuse and Mental Health Services. Risk and protective factors [ Internet]. Evidence Based Practices Resource Center. 2019 [accessed 2021 Mar 8]. https://www.samhsa.gov/sites/default/files/20190718-samhsa-risk-protective-factors.pdf .
- Centers for Disease Control and Prevention. Prevention: picture of America [ Internet]. [accessed 2021 Mar 8]. https://www.cdc.gov/pictureofamerica/pdfs/picture_of_america_prevention.pdf .
- Substance Abuse and Mental Health Services Administration. The opioid crisis and the Black/African American population: an urgent issue. Office of Behavioral Health Equity, Substance Abuse and Mental Health Services Administration; 2020. HHS Publication No. PEP20-05-02-001.
- Maryland Department of Health Public Health Administration. The Overdose Response Program [ Internet]. 2019 [accessed 2021 Mar 8]. https://health.maryland.gov/pha/NALOXONE/Pages/Home.aspx .
- Taylor MN, Shaya F, Pradhan A. Increase in availability of naloxone: a statewide look at standing orders impact on overdose deaths. Poster presented at: 2019 12th Annual Conference on the Science of Dissemination and Implementation; Arlington, VA; 2019.
- Oerther S, Oerther D. A population health perspective on America’s opioid addiction. Perspect Public Health. 2019 Jul;139:184–85. doi:https://doi.org/10.1177/1757913919851829.
- Maryland Department of Health Behavioral Health Administration. Unintentional drug and alcohol-related intoxication deaths [ Internet]. [accessed 2021 Mar 8]. https://bha.health.maryland.gov/overdose_prevention/pages/data-and-reports.aspx .
- U.S. Census Bureau. American Community Survey, 2015–2018 American Community Survey 1-year estimates. 2019.
- Pakhale S, Nur F, Bignell T, and Finnessy T. The social determinants of health. a deeper dive: health disparities in the nation’s capital. American Thoracic Society International Conference Meetings Abstracts American Thoracic Society International Conference Meetings Abstracts; American Thoracic Society; 2019; Dallas, TX. p. A6242–A6242.
- U.S. Census Bureau QuickFacts: United States [ Internet]. [accessed 2021 Sep 27]. https://www.census.gov/quickfacts/fact/table/US/PST045219 .
- Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pediatr. 2013;13:S38–44. doi:https://doi.org/10.1016/j.acap.2013.08.002.
- Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002 Aug;27:299–309. doi:https://doi.org/10.1046/j.1365-2710.2002.00430.x.
- Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008 Dec 16;3:17. doi:https://doi.org/10.1186/1751-0473-3-17.
- Choueiry G. Understand forward and backward stepwise regression – quantifying health. [last accessed 23 Aug 2021]. Available at: https://quantifyinghealth.com/stepwise-selection/ .
- SAS/ETS ® 13.2 user’s guide the EXPAND procedure. SAS Institute Inc.; 2014.
- Maryland Department of Health Behavioral Health Administration. Unintentional Drug and Alcohol-Related Intoxication Deaths in Maryland Annual Report 2017. Baltimore: Maryland Department of Health; 2017.
- Centers for Disease Control and Prevention. Fentanyl [ Internet]. 2020 [accessed 2021 Mar 8]. https://www.cdc.gov/drugoverdose/opioids/fentanyl.html .
- Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol. 2008 Jul;46:501–06. doi:https://doi.org/10.1080/15563650701877374.
- Dayton L, Gicquelais RE, Tobin K, Davey-Rothwell M, Falade-Nwulia O, Kong X, Fingerhood M, Jones AA, Latkin C. More than just availability: who has access and who administers take-home naloxone in Baltimore, MD. PLoS ONE. 2019;14:e0224686.
- Maryland Opioid Operational Command Center. Maryland State agencies working to combat heroin and opioid epidemic. 2017. [last accessed 20 Sep 2021]. Available at: https://beforeitstoolate.maryland.gov/maryland-state-agencies-working-to-combat-heroin-and-opioid-epidemic-2/ .
- Weil AR. Opioids, investing in social determinants, and more. Health Aff (Project Hope). 2020;39:183. NLM (Medline).
- Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, Beckwith CG, Linas BP, Walley AY. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019 Jul 1;200:59–63. doi:https://doi.org/10.1016/j.drugalcdep.2019.03.014.
- Tobin K, Clyde C, Davey-Rothwell M, Latkin C. Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade. Int J Drug Policy. 2018 Sep 1;59:94–97. doi:https://doi.org/10.1016/j.drugpo.2018.07.003.
- Centers for Disease Control and Prevention. Today’s heroin epidemic | VitalSigns | CDC [ Internet]. 2015 [accessed 2021 Apr 2]. https://www.cdc.gov/vitalsigns/heroin/index.html .
- Haines M, O’Byrne P. Harm reduction services in Ottawa: the culture of drug use. Res Theory Nurs Pract. 2020 May;34:188–202. doi:https://doi.org/10.1891/RTNP-D-19-00086.
- Lynn RR, Galinkin J. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018 Jan 1;9:63. doi:https://doi.org/10.1177/2042098617744161.
- Moss RB, Carlo DJ. Higher doses of naloxone are needed in the synthetic opioid era. Subst Abuse Treat Prev Policy. 2019 Feb 18;14:1–6. doi:https://doi.org/10.1186/s13011-019-0195-4.
- Hurt BR, Hussain A, Aledhaim A, Moayedi S, Schenkel SM, Kim HK. Access and barriers to take-home naloxone use among emergency department patients with opioid misuse in Baltimore, Maryland, USA. Subst Use Misuse. 2020 Oct 1;55:2237–42. doi:https://doi.org/10.1080/10826084.2020.1797811.
- Census Bureau U. American Community Survey accuracy of the data (2015). 2015.
- SAS Institute Inc. SAS/STAT ® 14.1 user’s guide the HPGENSELECT procedure. 2015.
- Chon DS. Medical resources and national homicide rates: a cross‐national assessment. J Comp Appl Criminal Justice. 2011 Mar;34:97–118. doi:https://doi.org/10.1080/0192403620109678819.
- Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017 Feb 1;46:348–55. doi:https://doi.org/10.1093/ije/dyw098.
- Hudson J, Fielding S, Ramsay CR. Methodology and reporting characteristics of studies using interrupted time series design in healthcare. BMC Med Res Methodol. 2019 Jul 4;19:137. doi:https://doi.org/10.1186/s12874-019-0777-x.